These findings may say a lot more about a patient's long-term health than clinicians realized. 

Using CT to perform coronary artery calcium scoring on symptomatic chest pain patients can deliver significant value, according to a new data published in Radiology. 

The new collaboration is designed to ensure patients who may face an increased risk of heart disease receive the follow-up care they need.

For this update to be finalized, the American Medical Association had to determine FFR_CT Analysis met certain requirements in terms of its overall impact on patient care. John Farquhar, CEO of HeartFlow, described the news as "a win for everyone involved, most notably patients." 

The company is still riding the momentum of its technology being included in the 2021 American College of Cardiology/American Heart Association chest pain guidelines.

“This type of screening could be used to identify individuals who would benefit from statin medication but are currently untreated," one specialist said. The full analysis will be presented at RSNA 2022 in Chicago. 

The FDA has had a busy month, overseeing the recall of nearly 88,000 implantable cardiac devices, juggling the continued rise of monkeypox cases in the United States and maintaining an active Breakthrough Devices program. This rundown covers some of the agency's biggest moves during that time. 

Signs of breast arterial calcification on a patient’s routine mammogram may suggest they face a greater risk of cardiovascular disease.